FDA Adverse Event Injury Summary report: N

COREVALVE 29MM AORTIC VALVE

MDR report key: 3895592 · Received June 25, 2014

Report

Report Number
2025587-2014-00418
Event Type
Injury
Date Received
June 25, 2014
Date of Event
May 30, 2014
Report Date
June 1, 2014
Manufacturer
MEDTRONIC HEART VALVES DIVISION
Product Code
NPT
PMA / PMN Number
P130021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PRODUCT ANALYSIS: THE PRODUCT REMAINS IMPLANTED AND THEREFORE HAS NOT BEEN RETURNED TO MEDTRONIC. CONDUCTION DISTURBANCES ARE KNOWN POTENTIAL ADVERSE EFFECTS ASSOCIATED WITH ANY CARDIAC OR THORACIC PROCEDURE (OPEN OR CATHETER-BASED) AND CAN BE RESOLVED WITH MEDICAL TREATMENT OR THE IMPLANT OF A PERMANENT PACEMAKER (WITH THE RISK-BENEFIT RATIO IN FAVOR OF IMPLANT OF THE PERCUTANEOUS AORTIC VALVE). A CONDUCTION DISTURBANCE DOES NOT INDICATE A DEVICE MALFUNCTION OR POTENTIAL MANUFACTURING ISSUE. THE DEVICE REMAINS IMPLANTED. (B)(4).

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION THAT 2 DAYS FOLLOWING THE IMPLANT OF THIS TRANSCATHETER BIOPROSTHETIC VALVE, ANEMIA RELATED TO PROCEDURAL BLOOD LOSS WAS NOTED. TWO UNITS OF BLOOD WERE TRANSFUSED AND THE ISSUE RESOLVED. THREE DAYS FOLLOWING IMPLANT, COMPLETE HEART BLOCK AND VENTRICULAR STANDSTILL WERE NOTED, REQUIRING 30 SECOND OF CARDIOPULMONARY RESUSCITATION (CPR). A TEMPORARY PACEMAKER WAS PLACED VIA THE RIGHT FEMORAL VEIN. FIVE DAYS POST-VALVE IMPLANT A DUAL CHAMBER PERMANENT PACEMAKER WAS IMPLANTED IN THE LEFT SUBCLAVIAN AREA, RESOLVING THE CONDUCTION DISTURBANCE. NO OTHER ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
371507 COREVALVE 29MM AORTIC VALVE AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED NPT MEDTRONIC HEART VALVES DIVISION MCS-P3-29-AOA

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention